Status:

TERMINATED

Development of New Prenatal Diagnostic Tests From Maternal Blood

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Hereditary Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inhe...

Eligibility Criteria

Inclusion

  • Mother and father-to-be both older than 18 years old
  • Mother and father-to-be affiliated to social security
  • Mother and father-to-be have good understanding of the protocol
  • Pregnancy of the mother-to-be attested

Exclusion

  • Mother and father-to-be are younger than 18 years old
  • Mother and/or father-to be refusing to participate

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2006

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00314691

Start Date

April 1 2006

End Date

September 1 2006

Last Update

July 28 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sihcus-Cmco

Strasbourg, Schiltigheim, France, 67300

Development of New Prenatal Diagnostic Tests From Maternal Blood | DecenTrialz